Bionik Laboratories Corp. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q3 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Bionik Laboratories Corp. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q3 2022 to Q1 2023.
  • Bionik Laboratories Corp. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending March 31, 2023 was $73.4K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $73.4K Mar 31, 2023 10-K 2023-06-21
Q4 2022 $77.3K Dec 31, 2022 10-Q 2023-02-08
Q3 2022 $82K Sep 30, 2022 10-Q 2022-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.